Mackay Shields LLC’s West Pharmaceutical WST Stock Holding History

Mackay Shields LLC’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,639	Closed	-$4.37M	–	706
2022 Q1	$4.37M	Sell	10,639 -421	-4%	-$165K	0.04%	392
2021 Q4	$5.19M	Sell	11,060 -228	-2%	-$98.1K	0.04%	362
2021 Q3	$4.79M	Sell	11,288 -326	-3%	-$137K	0.05%	347
2021 Q2	$4.17M	Sell	11,614 -679	-6%	-$224K	0.04%	377
2021 Q1	$3.46M	Sell	12,293 -674	-5%	-$193K	0.03%	563
2020 Q4	$3.67M	Sell	12,967 -25,055	-66%	-$7.03M	0.03%	584
2020 Q3	$10.5M	Sell	38,022 -21,090	-36%	-$5.58M	0.07%	294
2020 Q2	$13.4M	Buy	59,112 +39,862	+207%	+$7.83M	0.11%	223
2020 Q1	$2.93M	Sell	19,250 -20,342	-51%	-$3.13M	0.03%	512
2019 Q4	$5.95M	Buy	+39,592	New	+$5.76M	0.04%	433

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Mackay Shields LLC's WST Position: Q2 2022 in Review

Mackay Shields LLC sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 10,639 shares — an estimated $4.37M sold.

Mackay Shields LLC first reported a position in WST in Q4 2019 and held it in 10 quarters. The position peaked at $13.4M in Q2 2020. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

Mackay Shields LLC reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
Mackay Shields LLC sold 10,639 West Pharmaceutical shares in Q2 2022, an estimated $4.37M.
Mackay Shields LLC first reported a position in West Pharmaceutical in Q4 2019 and held it in 10 quarters.
Mackay Shields LLC's West Pharmaceutical position peaked at $13.4M in Q2 2020.
655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.